St. Jude Medical Announces Increase in Quarterly Dividend

Board of Directors declares 7 percent increase in quarterly dividend

ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced that its board of directors declared a 7 percent increase in the company’s quarterly dividend to $0.31 per common share. The dividend is payable April 29, 2016, to shareholders of record on March 31, 2016. At the new rate, the annual dividend would be $1.24 per share, compared to the previous annual dividend of $1.16 per share.

About St. Jude Medical

St. Jude Medical is a leading global medical device manufacturer and is dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. The Company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management, and cardiovascular diseases. For more information, please visit sjm.com or follow us on Twitter @StJudeMedicalIR.

Forward-Looking StatementsThis news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the Company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the Company’s control and the risk factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the Company’s Annual Report on Form 10-K for the fiscal year ended January 3, 2015 and Quarterly Report on Form 10-Q for the fiscal quarter ended October 3, 2015. The Company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160219005860/en/

St. Jude Medical, Inc.
J.C. Weigelt, 651-756-4347
Investor Relations
[email protected]
or
Candace Steele Flippin, 651-756-3029
Media Relations
[email protected]

Source: St. Jude Medical, Inc.

You May Also Be Interested In

• Dubai's VARA and Securitize sign MoU on tokenized markets
• DSS, Inc. launches public stock offering on NYSE American
• Bally's CFO resigns; president named interim replacement